These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 4049780)
21. [Fibrinolytic activity of acyl-urokinase]. Stürzebecher J; Kroneck I; Klöcking HP Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):137-43. PubMed ID: 2427394 [TBL] [Abstract][Full Text] [Related]
22. [Drug preparations of immobilized enzymes with enhanced affinity for the site of action]. Torchilin VP; Maksimenko AV; Tishchenko EG; Papisov MI; Smirnov VN Antibiot Med Biotekhnol; 1986 Feb; 31(2):122-7. PubMed ID: 2421639 [TBL] [Abstract][Full Text] [Related]
23. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species. Lijnen HR; De Wreede K; Demarsin E; Collen D Thromb Haemost; 1984 Aug; 52(1):31-3. PubMed ID: 6495261 [TBL] [Abstract][Full Text] [Related]
24. Blood coagulation changes during effective thrombolysis using urokinase and heparin. Schöffel G; Zimmermann R; Harenberg J; Mörl H Thromb Res; 1982 Jan 1-15; 25(1-2):11-21. PubMed ID: 6175040 [TBL] [Abstract][Full Text] [Related]
25. Urokinase immobilized on medical polymeric materials: fundamental and clinical studies. Ohshiro T; Kosaki G Artif Organs; 1980 Feb; 4(1):58-4. PubMed ID: 6989347 [TBL] [Abstract][Full Text] [Related]
26. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy]. Veremeenko KN; Kizim AI Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892 [TBL] [Abstract][Full Text] [Related]
27. In vitro potentiation of urokinase-activated lysis of human fibrin clots. Singh K; Vézina C J Med; 1974; 5(6):297-302. PubMed ID: 4528600 [No Abstract] [Full Text] [Related]
28. Antiplatelet effects of urokinase and their clinical implications. Torr-Brown SR; Sobel BE Coron Artery Dis; 1996 Jan; 7(1):63-8. PubMed ID: 8773435 [TBL] [Abstract][Full Text] [Related]
29. [Combined thrombolysis by pharmacokinetically different plasminogen activators]. Maksimenko AV Bioorg Khim; 1998 May; 24(5):376-80. PubMed ID: 9661792 [TBL] [Abstract][Full Text] [Related]
30. [Antithrombogenic effect of urokinase bound to the collagen surface with bifunctional antibodies]. Stepanova IP; Tsybul'skaia MV; Domogatskiĭ SP Biull Eksp Biol Med; 1994 May; 117(5):504-7. PubMed ID: 9296703 [No Abstract] [Full Text] [Related]
31. The preparation of a urokinase-AT-III-PGE1-methyldopa complex, and its effects on platelet adhesion, coagulation times, protein adsorption, and fibrinolysis. Chandy T; Sharma CP Artif Organs; 1989 Jun; 13(3):229-37. PubMed ID: 2764762 [TBL] [Abstract][Full Text] [Related]
32. Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin. Samama M; Castel M; Matsuo O; Hoylaerts M; Lijnen HR Thromb Haemost; 1982 Feb; 47(1):36-40. PubMed ID: 7041325 [TBL] [Abstract][Full Text] [Related]
33. Magnetic urokinase: targeting of urokinase to fibrin clot. Yoshimoto T; Ohwada K; Takahashi K; Matsushima A; Saito Y; Inada Y Biochem Biophys Res Commun; 1988 Apr; 152(2):739-43. PubMed ID: 3365251 [TBL] [Abstract][Full Text] [Related]
34. [Fibrinolytic properties and thrombolytic effect of a novel fibrinolytic enzyme from Streptomyces sp. Y405]. Wang M; Wang J; Shao M; Wang M; Wang Y Yao Xue Xue Bao; 1998 Jul; 33(7):481-5. PubMed ID: 12016879 [TBL] [Abstract][Full Text] [Related]